Samuel F. Gilbert - Concepedia

Author

Samuel F. Gilbert

University of Michigan ORCID

Also Known As

Dan Brounstein, S. Gilbert, Samuel F Gilbert, Samuel F. Gilbert, Samuel Gilbert

Publications

695

Citations

H-Index

Concepts

All Affiliations

University of Michigan San Diego State University Beaumont Hospital, Royal Oak Western Michigan University Johns Hopkins University

About

Samuel F. Gilbert is an author at University of Michigan specializing in medicine, radiation oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	330
2	Health Sciences	2	2	222
3	Natural Sciences	1	1	20
4	Biochemistry	1	1	20
5	Cell Biology	1	1	77

Samuel F. Gilbert

Publications

586

Citations

H-Index

Page 1

	Year	Citations
Analysis of Treatment Efficacy, Cosmesis, and Toxicity Using the MammoSite Breast Brachytherapy Catheter to Deliver Accelerated Partial-Breast Irradiation: The William Beaumont Hospital Experience K. Chao, Frank A. Vicini, Michelle Wallace, International Journal of Radiation OncologyBiologyPhysics Toxicity UsingRadiation MedicineBreast OncologyRadiation TherapyRadiobiology	2007	135
<i>PIK3CA</i> and <i>AKT1</i> Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System Julia A. Beaver, John P. Gustin, Kyung Hee Yi, Clinical Cancer Research	2013	102
Long-Term Efficacy and Patterns of Failure After Accelerated Partial Breast Irradiation: A Molecular Assay–Based Clonality Evaluation Frank A. Vicini, J. Vito Antonucci, Michelle Wallace, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineBreast OncologyRadiation TherapyLong-term EfficacyMedicine	2007	87
Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells Mikella Robinson, Samuel F. Gilbert, Jennifer A. Waters, Cancers Developmental BiologyEndocrine-related CancerTumor-initiating CellsMedicineOncogenic Agent	2021	77
MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer Yoshimi Endo Greer, Samuel F. Gilbert, Brunilde Gril, Breast Cancer Research	2019	69
The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in‐breast failure in patients with early‐stage breast cancer treated with breast‐conserving therapy Frank A. Vicini, J. Vito Antonucci, Neal S. Goldstein, Cancer	2007	45
Biological clues to potent DNA-damaging activities in food and flavoring M. Zulfiquer Hossain, Samuel F. Gilbert, Kalpesh Patel, Food and Chemical Toxicology Biological CluesBiochemistryNatural SciencesGeneticsMolecular Biology	2013	20
TWEAK–Fn14–RelB Signaling Cascade Promotes Stem Cell–like Features that Contribute to Post-Chemotherapy Ovarian Cancer Relapse Ryne Holmberg, Mikella Robinson, Samuel F. Gilbert, Molecular Cancer Research	2022	17
Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients Samuel F. Gilbert, Amr S. Soliman, Mehdi Karkouri, Breast Disease	2011	13
Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients Samuel F. Gilbert, Amr S. Soliman, Maria D. Iniesta, Breast Cancer Research and Treatment UrologyBreast OncologyHormonal ReceptorGynecologyBreast Cancer	2011	11

Page 1